Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Sales |
559.53 |
538.21 |
577.54 |
591.63 |
696.41 |
Operating profit |
69.06 |
59.74 |
65.42 |
71.90 |
88.52 |
Interest |
8.09 |
6.75 |
7.55 |
7.77 |
8.35 |
Gross profit |
62.08 |
54.67 |
58.61 |
64.79 |
81.10 |
EPS (Rs) |
3.93 |
3.44 |
3.76 |
4.27 |
5.74 |
Quarterly
results in details
|
Mar' 24 |
Dec' 23 |
Sep' 23 |
Jun' 23 |
Mar' 23 |
Other income |
1.11 |
1.68 |
0.74 |
0.66 |
0.93 |
Stock adjustment |
14.50 |
28.17 |
-8.62 |
-7.28 |
44.67 |
Raw material |
345.65 |
329.93 |
391.97 |
399.02 |
435.39 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
19.94 |
20.24 |
20.04 |
20.66 |
21.10 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
110.38 |
100.13 |
108.73 |
107.33 |
106.73 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
12.34 |
11.80 |
11.78 |
11.75 |
11.68 |
Taxation |
13.60 |
11.25 |
12.25 |
13.50 |
16.25 |
Net profit / loss |
36.14 |
31.62 |
34.58 |
39.54 |
53.17 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
91.94 |
91.94 |
91.94 |
92.60 |
92.60 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
12.34 |
11.10 |
11.33 |
12.15 |
12.71 |
GPM (%) |
11.07 |
10.13 |
10.14 |
10.94 |
11.63 |
NPM (%) |
6.45 |
5.86 |
5.98 |
6.68 |
7.62 |